Major Funding Day: AI Drug Discovery and Automation Drive Billion-Dollar Rounds
May 13, 2026, delivered some of the year's most significant funding announcements, with AI-powered drug discovery and business automation leading massive investment rounds across Europe and beyond.
Mega Rounds: Billion-Dollar Valuations
The day's standout was Isomorphic Labs, the DeepMind spinout founded by Sir Demis Hassabis, which secured a staggering $2.1B investment to advance its AI-driven drug discovery platform. This represents one of the largest biotech funding rounds in recent history, signaling massive investor confidence in AI's potential to revolutionize pharmaceutical development.
Meanwhile, Berlin-based N8n saw its valuation more than double to $5.2B following a strategic investment from German software giant SAP. The business automation platform's meteoric rise reflects the growing enterprise demand for workflow automation solutions.
Growth Stage: Fintech and AI Infrastructure
Several notable growth-stage rounds demonstrated continued strength in fintech and AI infrastructure:
- Paymentology raised $175M co-led by Apis Partners and Aspirity Partners to expand its global issuer-processing platform for banks and fintechs
- Adfin secured €15.3M ($18M) in Series A led by Index Ventures for its AI-powered revenue collection platform
- Webidoo closed €21M ($25M) led by IXC3 to scale its SMB-focused AI automation platform across Europe
Seed and Early Stage: AI Across Sectors
The seed funding landscape was dominated by AI applications across diverse verticals:
- Pillar raised €12M led by Earlybird Venture Capital and Base10 Partners for its AI-powered construction operating system
- White Circle secured $11M in seed funding for enterprise AI governance and security solutions
- Ditto closed €7.6M led by Heal Capital to expand its AI-powered patient communication platform across Europe
- Dessn raised €5M led by Connect Ventures for its AI design-in-production platform
Regional Activity and Specialized Sectors
Notable regional funding included several Indian companies making significant raises:
- Dil Foods secured Rs 72 Cr ($8.6M) in Series B for product diversification
- HrdWyr raised $13M in Series A led by Ideaspring Capital for semiconductor development
- Mekr closed Rs 67 Cr ($8M) in Series A for consumer electronics manufacturing
Smaller but strategic rounds included Ventory raising €2.65M led by KBC Securities for inventory management, Holmes launching with €1.1M pre-seed for autonomous software testing, and Tolemy Bio securing €1.4M for AI-driven cell biology research.
Market Signal: AI's Infrastructure Moment
Today's funding announcements paint a clear picture of AI moving beyond experimental applications into critical infrastructure roles. The massive rounds for Isomorphic Labs and N8n suggest investors are betting on AI's ability to transform fundamental business processes, from drug discovery to workflow automation. The breadth of AI-focused seed rounds across construction, healthcare, fintech, and cybersecurity indicates this transformation is accelerating across virtually every sector. This signals we're entering a mature phase where AI companies are building the foundational tools that will power the next decade of business innovation.